AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.
Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform ...
Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results